Peter Navarro, a White House economic adviser who is part of the Chinese Communist Party’s anti-coronavirus task force, said Thursday that the United States would soon return to manufacturing medical supplies to break its dependence on other countries.

Navarro said that given the current crisis that the United States was pushed into, federal departments, as well as the Veterans Affairs Department and the Defense Department need to purchase the medical supplies and other health equipment manufactured in the United States.

According to the Washington Examiner, Navarro, who is also the national coordinator of the Defense Production Act, said: “Never again should we rely on the rest of the world for our essential medicines and countermeasures.”

“One of the things that this crisis has taught us is that we are dangerously overdependent on a global supply chain (…) For our medicines like penicillin, our medical supplies, masks, and our medical equipment like ventilators,” Navarro added.

Navarro also said that the Food and Drug Administration (FDA) would have to approve the manufacture of drugs in the United States so that American manufacturers could compete against imports.

That would end the need to compete against cheap labor as well as lax environmental regulations and different tax regimes, the Washington Examiner said.

Navarro, who recently became the policy coordinator of the Defense Production Act, has as his main objective to prevent “bottlenecks or delays” in the production of medical supplies to combat the CCP Virus.

According to Fox News, Navarro was pleased with the diligent progress being made by many companies in the face of the national emergency that the country is experiencing due to the pandemic.

“The president has mobilized the full force of the federal government, but we’ve also seen the full power of private enterprise join hands with us,” Navarro said, acknowledging the number of “good stories” that have been come out about what the private sector is doing to help at this critical time.

Last week, with the federal government’s implementation of the Defense Protection Act, General Motors announced the reopening of one of its idle plants in Michigan, now destined to produce facial masks en masse.

Meanwhile, the FDA has recently authorized the first coronavirus test that measures antibodies in the blood, so it is expected to study people who have recovered from the disease and discover who is immune to eventually contribute to the development of a vaccine.